Yonhap KoreanKO
셀트리온 "4중 작용 비만약, 비임상서 체중 감량 효과"
(서울=연합뉴스) 박상현 기자 = 셀트리온[068270]은 차세대 4중 작용 비만치료제 후보물질 'CT-G32/SCO-940'의 비임상에서 체중...
🇰🇷 대한민국 / 한국어
The world, in perspective.
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.